Monitoring the safety of AVEIR leadless pacemakers
Part of Heart & circulation clinical trials.
This study tracks the safety and performance of AVEIR VR LP and AVEIR AR LP leadless pacemakers in people who already have them or will get one. It helps doctors and researchers see how well these small heart devices work over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been or will be given an AVEIR VR LP or AVEIR AR LP leadless pacemaker.
- You understand the study and agree to be part of it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why people get a certain type of pacemaker (a leadless pacemaker that works without wires) and how it helps the upper and lower chambers of the heart beat together. If you have a heart block and need a pacemaker, this research might help doctors understand the best way to treat people like you.
This study is an observational registry for people who have or will receive an AVEIR leadless pacemaker. It collects information to help doctors understand how the device performs over time.
This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.
This study uses your medical records from Medicare to learn how the Aveir DR leadless pacemaker performs in everyday life after it’s implanted. It mainly helps researchers and doctors understand real-world outcomes and care needs.
This trial tests a new pacemaker system for people who need a pacemaker for a slow or irregular heartbeat. It aims to see if the system is safe and works well.
This trial is for people who already have an Aveir leadless pacemaker and either were in a previous study or need to upgrade from a single-chamber to a dual-chamber system. It helps monitor the device's performance in real-world use.
Hear when a new Pacemaker trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.